Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$0.38 - $1.05 $6,361 - $17,578
16,741 Added 13.91%
137,102 $57,000
Q3 2021

Nov 12, 2021

BUY
$1.15 - $1.62 $46,908 - $66,079
40,790 Added 51.26%
120,361 $143,000
Q2 2021

Aug 13, 2021

BUY
$1.31 - $2.14 $79,620 - $130,067
60,779 Added 323.43%
79,571 $127,000
Q2 2020

Aug 13, 2020

BUY
$2.53 - $4.08 $47,543 - $76,671
18,792 New
18,792 $48,000

Others Institutions Holding HOTH

About Hoth Therapeutics, Inc.


  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.11M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.